yoteki

Tech&Science · Important news for 11 August 2026

Tech&Science

Experimental GLP-1 Pill Aleniglipron Shows 12% Weight Loss in Trial

ScienceDaily

An experimental daily oral GLP-1 pill, aleniglipron, demonstrated up to 12.1% weight loss over 36 weeks in a clinical trial, offering an easier-to-produce alternative to injectables.

That's all the important news for now

Everything above cleared the significance threshold. You're free.